vTv Therapeutics (VTVT) Current Assets (2014 - 2026)

vTv Therapeutics (VTVT) has 13 years of Current Assets data on file, last reported at $98.8 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 209.59% year-over-year to $98.8 million; the trailing twelve-month figure through Mar 2026 stood at $98.8 million (up 209.59% YoY), and the FY2025 full-year result was $89.9 million, up 135.86% from the prior year.
• Current Assets improved to $98.8 million in Q1 2026, from $89.9 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $99.5 million in Q3 2025 to a low of $10.1 million in Q3 2023.
• A 5-year average of $40.2 million and a median of $30.6 million in 2022 frame the typical range for Current Assets.
• Across the five-year window, Current Assets slumped 64.82% in 2023 and jumped 324.28% in 2024, its largest moves.
• Tracing VTVT's Current Assets over 5 years: stood at $27.1 million in 2022, then tumbled by 60.67% to $10.7 million in 2023, then surged by 257.63% to $38.1 million in 2024, then soared by 135.86% to $89.9 million in 2025, then advanced by 9.92% to $98.8 million in 2026.
• Business Quant data shows VTVT's Current Assets at $98.8 million in Q1 2026, $89.9 million in Q4 2025, and $99.5 million in Q3 2025.